Attached files
| file | filename |
|---|---|
| EX-99 - EXHIBIT 99.1 - VBI VACCINES INC. | ex99-1.htm |
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|
Date of Report: July 15, 2014 (Date of earliest event reported) | ||
|
Paulson Capital (Delaware) Corp. (Exact name of registrant as specified in its charter) | ||
|
Delaware (State or other jurisdiction of incorporation) |
0-18188 (Commission File Number) |
93-0589534 (IRS Employer Identification Number) |
|
1331 NW Lovejoy Street, Suite 720 Portland, Oregon (Address of principal executive offices) |
97209 (Zip Code) | |
|
503-243-6000 (Registrant’s telephone number, including area code) | ||
|
Not Applicable (Former Name or Former Address, if changed since last report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On July 15, 2014, the Company issued a press release describing the results of the Special Meeting of it Stockholders and the related merger proposal involving Variation Biotechnologies (US), Inc. A copy of the press release is filed herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit No. |
Description | |
|
99.1 |
Press Release, issued by Paulson Capital (Delaware) Corp. on July 15, 2014 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Dated: July 15, 2014 |
PAULSON CAPITAL |
||
| (DELAWARE) CORP. | |||
|
By: |
/s/ Murray G. Smith |
||
|
Murray G. Smith |
|||
|
Chief Financial Officer |
|||
EXHIBIT INDEX
|
Exhibit No. |
Description | |
|
99.1 |
Press Release, issued by Paulson Capital (Delaware) Corp. on July 15, 2014 |